All lobbying filings
MILLER STRATEGIES, LLC
MILLER STRATEGIES, LLC filed a Q4 report for AMGEN, INC. on January 20, 2026, reporting $60,000 in lobbying income.
Lobbying for AMGEN, INC. · biopharmaceutical company
Filing · LD-2 quarterly report
Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Income
$60,000
What the client paid this registrant for the period.
Client based in
District of Columbia
Lobbying activity
3
Healthcare policy issues as they relate to the pharmaceutical industry including drug pricing and biosimilars
Issues related to drug pricing, biosimilars, Medicare Part D and Medicare Part B; H.R. 3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021
Issues related to visas
Bills named in this filing
1